Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controllled, phase 3 study

the RADIANT-2 study group, Matti Välimäki

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
TidskriftLancet
Volym378
Sidor (från-till)2005-2012
ISSN0140-6736
StatusPublicerad - 2011
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3121 Inre medicin

Citera det här

@article{3f53a2b60fb14773a6336b85b10922b7,
title = "Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controllled, phase 3 study",
keywords = "3121 Internal medicine",
author = "Pavel, {Marianne E.} and Hainsworth, {John D.} and Eric Baudin and Marc Peeters and Dieter H{\"o}rsch and Winkler, {Robert E.} and Judith Klimovsky and David Lebwohl and Valentine Jehl and Wolin, {Edward M.} and Kjell {\"O}berg and {van Cutsem}, Erc and Yao, {James C.} and {the RADIANT-2 study group} and Matti V{\"a}lim{\"a}ki",
year = "2011",
language = "English",
volume = "378",
pages = "2005--2012",
journal = "Lancet",
issn = "0140-6736",
publisher = "EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC",

}

TY - JOUR

T1 - Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controllled, phase 3 study

AU - Pavel, Marianne E.

AU - Hainsworth, John D.

AU - Baudin, Eric

AU - Peeters, Marc

AU - Hörsch, Dieter

AU - Winkler, Robert E.

AU - Klimovsky, Judith

AU - Lebwohl, David

AU - Jehl, Valentine

AU - Wolin, Edward M.

AU - Öberg, Kjell

AU - van Cutsem, Erc

AU - Yao, James C.

AU - the RADIANT-2 study group

AU - Välimäki, Matti

PY - 2011

Y1 - 2011

KW - 3121 Internal medicine

M3 - Article

VL - 378

SP - 2005

EP - 2012

JO - Lancet

JF - Lancet

SN - 0140-6736

ER -